Novel drugs for systemic targeted radiation therapy
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
70
NCT05017662
A Long-term Safety Surveillance Study in Participants Previously Treated With 177Lu-IPN01072
Phase: N/A
Role: Lead Sponsor
Start: Sep 14, 2021
Completion: Apr 29, 2025
NCT06939036
Study of 225Ac-SS0110 in Subjects With ES-SCLC or MCC (SANTANA-225 )
Phase: Phase 1/2
Start: Jul 1, 2025
Completion: Dec 31, 2026
Loading map...